Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

COR Therapeutics, Inc. to Report / Webcast Third Quarter 2001 Financial Results Wednesday, October 24, 2001.


Business & Health Editors

SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--Oct. 18, 2001

COR Therapeutics, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CORR CORR

Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51.
) announced today that it will release its third quarter 2001 financial results on Wednesday, October 24, 2001, after the markets close.

At 5:00 p.m. EDT (2:00 p.m. PDT), on Wednesday, October 24, 2001, as part of the Company's efforts to ensure full disclosure to all parties, COR will webcast live its conference call to discuss its results and outlook, which will be led by Vaughn M. Kailian, President and Chief Executive Officer.

The webcast may be accessed by logging onto either http://www.corr.com or http://www.vcall.com/NASApp/VCall/EventPage?ID=78786 on the internet. Please connect to either website at least 10 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the live webcast. In addition, the webcast will be archived and will be available for five business days.

COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction (·kyōōtˑ mī·ō·karˑ·dē· , deep vein thrombosis A blood clot (thrombos) in a vein deep within the muscle, typically in the thigh or calf. It is caused by disease or the lack of activity such as sitting for hours at a computer screen. , and restenosis.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 18, 2001
Words:217
Previous Article:NetGenesis Third Quarter 2001 Conference Call to be Broadcast Live Over the Internet.
Next Article:Charlotte Russe "Stands United".
Topics:



Related Articles
COR Therapeutics, Inc. to Release / Webcast Third Quarter Financial Results Tuesday, October 17, 2000.
COR Therapeutics, Inc. Announces Increased Sales of INTEGRILIN -eptifibatide- Injection and Third Quarter 2000 Financial Results.
COR Therapeutics, Inc. Reports Significant Draw Down of Wholesaler Inventory;.
COR Therapeutics, Inc. to Report / Webcast First Quarter 2001 Financial Results Tuesday, April 17, 2001.
COR Therapeutics, Inc. Reports First Quarter 2001 Financial Results.
COR Therapeutics, Inc. to Report / Webcast Second Quarter 2001 Financial Results Tuesday, July 17, 2001.
COR Therapeutics, Inc. Reports Profitable Second Quarter Driven by 60 Percent Year-Over-Year INTEGRILIN Sales Growth.
COR Therapeutics, Inc. Resets Guidance for Third Quarter and Year-End 2001.
COR Therapeutics, Inc. Reports Profitable Third Quarter.
Convertibles make the difference: Tracy Maitland's convertible securities strategy lessened market risk. (Stock Update).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles